Research programme: quinolone antibiotics - Il Dong PharmaceuticalsAlternative Names: IDQ-8006
Latest Information Update: 16 Jul 2016
At a glance
- Originator Il Dong
- Class Quinolones
- Mechanism of Action DNA topoisomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in South Korea
- 29 Jun 2011 Preclinical trials in Bacterial infections in South Korea (unspecified route)